 |
|
Fractional PhotothermolysisA New Therapeutic Modality for Xanthelasma
Tracy M. Katz, MD;
Leonard H. Goldberg, MD;
Paul M. Friedman, MD
Arch Dermatol. 2009;145(10):1091-1094.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
Xanthelasma of the eyelid is an asymptomatic and not uncommon disease with cosmetic consequences that drive the patient to seek medical treatment.
REPORT OF A CASE
A 52-year-old Asian woman with skin type IV presented with a 4-year history of xanthelasma on her face, including her cheeks, upper eyelids, and inner canthi. She also reported a more than 20-year medical history of hypothyroidism, for which she had been taking thyroid hormone replacement during that time. No other medical history was reported. A punch biopsy specimen demonstrated aggregates of histiocytes with small round nuclei and abundant foamy cytoplasm extending 0.39 mm into the upper reticular dermis. These findings were consistent with xanthelasma. At that time, the patient was referred to her primary care physician to undergo workup for dyslipidemia. Her blood cholesterol levels were found to be elevated (total cholesterol, 303 mg/dL; low-density . . . [Full Text of this Article]
THERAPEUTIC CHALLENGE
SOLUTION
COMMENT
AUTHOR INFORMATION
DermSurgery Associates (Drs Katz, Goldberg, and Friedman) and Departments of Dermatology, Weill Cornell Medical College, The Methodist Hospital (Drs Goldberg and Friedman), and The University of Texas Medical School (Drs Goldberg and Friedman), Houston
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
